EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report

Katherine M Burnand, Jonathan Neville iD, Annita Budzanowski, Bruce O Okoye, Kate Cross, Kate Wheeler, Juliet Gray, Nigel Hall, Ramya Ramanujakar, Snigdha Reddy, Max Pachl iD, Carla Kierulff und 21 weitere

Pediatric Blood & Cancer · 2025-02 · 72 (2)

DOI: 10.1002/pbc.31445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 24.11.2024. Verfasst von Katherine M Burnand und 32 weiteren Autor:innen. Beteiligte Einrichtung: The Royal Marsden NHS foundation Trust, London, UK. Hauptthemen laut MEDLINE: Ganglioneuroma, Ganglioneuroblastoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ganglioneuroblastoma intermixed (GNBi) and ganglioneuroma (GN) represent benign variants of peripheral neuroblastic tumours. While historically surgical resection was recommended, watchful active observation has become the accepted management for a subset of patients.

Objectives

To review clinical features, biology, natural history and management of a retrospective UK CCLG study cohort of GN and GNBi, and compare outcomes of patients treated with surgical resection or watchful active observation.

Methods

Retrospective review of histologically confirmed non‐metastatic GN and GNBi diagnosed between 1990 and 2020.

Results

A total of 259 patients were identified (163 GN, 93 GNBi, median age 62 months). In all 201 (78%) had initial surgery and 58 (22%) were observed. Overall survival was 98%. Twenty‐one of 58 observed (36%) required subsequent surgery due to progressive tumour growth (52%). Gross total resection (GTR) was achieved in 79% of patients with a 19% complication rate. GTR was obtained in a similar proportion of patients having initial surgery (65%) and delayed surgery (76%). Patients obtaining GTR were more likely to have complete symptom(s) control (43% vs. 24%). In 45 cases (39%), surgical pathology was different from pathology at biopsy, and in 14 (12%) the pathology changed from GN/GNBi to neuroblastoma/GNB nodular.

Conclusion

Watchful active observation can be a safe approach, with surgical resection reserved for symptomatic patients. However, a small proportion of patients in the observation group had their diagnosis revised to malignant at surgery. Careful assessment of surgical risk and expected benefits, after considering an initial period of observation, will allow clinicians to make optimal decisions for patients and their families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GanglioneuromaGanglioneuroblastomaHumansFemaleMaleChild, PreschoolRetrospective StudiesUnited KingdomChildInfantAdolescentSurvival RateWatchful WaitingFollow-Up StudiesPrognosisDisease Management

Stichwörter der Autor:innen

ganglioneuroblastomaganglioneuromaobservationsurgerysurveillance

Autor:innen und Institutionen

  • The Royal Marsden NHS foundation Trust, London, UK.
  • Department of Paediatric Oncology, Southampton Children's Hospital, Southampton, UK.
  • Department of Paediatric Oncology, Great Ormond Street Hospital, London, UK.
  • Department of Paediatric Oncology, Oxford Children's Hospital, Oxford, UK.
  • Department of Paediatric surgery, Birmingham Children's Hospital, Birmingham, UK.
  • Department of Paediatric Oncology, Royal Aberdeen Children's Hospital, Aberdeen, UK.

ORCID-Profile: Jonathan Neville, Max Pachl, Sarah Braungart, Hany Gabra

Zitieren

APA

Burnand, K. M., Neville, J., Budzanowski, A., Okoye, B. O., Cross, K., Wheeler, K., Gray, J., Hall, N., Ramanujakar, R., Reddy, S., Pachl, M., Kierulff, C., Herd, F., Makin, G., Howell, L., Pizer, B., Rogers, T., Al-Khafaji, N., Tweddle, D., …, & Gabra, H. (2025). Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report. Pediatric Blood & Cancer, 72(2). https://doi.org/10.1002/pbc.31445

Vancouver

Burnand KM, Neville J, Budzanowski A, Okoye BO, Cross K, Wheeler K, et al. Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report. Pediatric Blood & Cancer. 2025;72(2). doi:10.1002/pbc.31445

BibTeX
@article{Burnand2025,
  author = {Burnand, Katherine M and Neville, Jonathan and Budzanowski, Annita and Okoye, Bruce O and Cross, Kate and Wheeler, Kate and Gray, Juliet and Hall, Nigel and Ramanujakar, Ramya and Reddy, Snigdha and Pachl, Max and Kierulff, Carla and Herd, Fiona and Makin, Guy and Howell, Lisa and Pizer, Barry and Rogers, Timothy and Al-Khafaji, Nadeem and Tweddle, Deborah and Carruthers, Vicky-Anne and Barone, Giuseppe and Anderson, John and Vaidya, Sucheta and George, Sally and Braungart, Sarah and Kwok, Chun and Jacovides, Michael and Burke, Amos and Yeomanson, Dan and Murphy, Dermot and Losty, Paul D and Angelini, Paola and Gabra, Hany},
  title = {Management of Ganglioneuroma and Ganglioneuroblastoma Intermixed: A United Kingdom Children's Cancer and Leukaemia Group (UK CCLG) Nationwide Study Report},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  volume = {72},
  number = {2},
  doi = {10.1002/pbc.31445}
}
Kostenlos starten →